Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry

Stölzl D, Sander N, Heratizadeh A, Haufe E, Harder I, Abraham S, Heinrich L, Kleinheinz A, Wollenberg A, Weisshaar E, Schäkel K, et al. (2022)
British Journal of Dermatology 187(6): 1022–1024.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Stölzl, Dora; Sander, Nicole; Heratizadeh, Annice; Haufe, Eva; Harder, Inken; Abraham, Susanne; Heinrich, Luise; Kleinheinz, Andreas; Wollenberg, Andreas; Weisshaar, Elke; Schäkel, Knut; Ertner, Konstantin
Alle
Erscheinungsjahr
2022
Zeitschriftentitel
British Journal of Dermatology
Band
187
Ausgabe
6
Seite(n)
1022–1024
ISSN
0007-0963
eISSN
1365-2133
Page URI
https://pub.uni-bielefeld.de/record/2968736

Zitieren

Stölzl D, Sander N, Heratizadeh A, et al. Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry. British Journal of Dermatology. 2022;187(6):1022–1024.
Stölzl, D., Sander, N., Heratizadeh, A., Haufe, E., Harder, I., Abraham, S., Heinrich, L., et al. (2022). Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry. British Journal of Dermatology, 187(6), 1022–1024. https://doi.org/10.1111/bjd.21794
Stölzl, Dora, Sander, Nicole, Heratizadeh, Annice, Haufe, Eva, Harder, Inken, Abraham, Susanne, Heinrich, Luise, et al. 2022. “Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry”. British Journal of Dermatology 187 (6): 1022–1024.
Stölzl, D., Sander, N., Heratizadeh, A., Haufe, E., Harder, I., Abraham, S., Heinrich, L., Kleinheinz, A., Wollenberg, A., Weisshaar, E., et al. (2022). Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry. British Journal of Dermatology 187, 1022–1024.
Stölzl, D., et al., 2022. Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry. British Journal of Dermatology, 187(6), p 1022–1024.
D. Stölzl, et al., “Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry”, British Journal of Dermatology, vol. 187, 2022, pp. 1022–1024.
Stölzl, D., Sander, N., Heratizadeh, A., Haufe, E., Harder, I., Abraham, S., Heinrich, L., Kleinheinz, A., Wollenberg, A., Weisshaar, E., Schäkel, K., Ertner, K., Wiemers, F., Wildberger, J., Worm, M., von Kiedrowski, R., Effendy, I., Asmussen, A., Augustin, M., Pawlak, M., Sticherling, M., Zink, A., Hilgers, M., Handrick, C., Quist, S.R., Schwarz, B., Staubach-Renz, P., Bell, M., Hong-Weldemann, S.-H., Homey, B., Brücher, J.-J., Schmitt, J., Werfel, T., Weidinger, S.: Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry. British Journal of Dermatology. 187, 1022–1024 (2022).
Stölzl, Dora, Sander, Nicole, Heratizadeh, Annice, Haufe, Eva, Harder, Inken, Abraham, Susanne, Heinrich, Luise, Kleinheinz, Andreas, Wollenberg, Andreas, Weisshaar, Elke, Schäkel, Knut, Ertner, Konstantin, Wiemers, Franca, Wildberger, Julia, Worm, Margitta, von Kiedrowski, Ralph, Effendy, Isaak, Asmussen, Andrea, Augustin, Matthias, Pawlak, Mario, Sticherling, Michael, Zink, Alexander, Hilgers, Melanie, Handrick, Christiane, Quist, Sven R., Schwarz, Beate, Staubach-Renz, Petra, Bell, Magnus, Hong-Weldemann, Sun-Hei, Homey, Bernhard, Brücher, Jens-Joachim, Schmitt, Jochen, Werfel, Thomas, and Weidinger, Stephan. “Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry”. British Journal of Dermatology 187.6 (2022): 1022–1024.
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 35895855
PubMed | Europe PMC

Suchen in

Google Scholar